Literature DB >> 4135401

Absence of the 9q plus chromosome in Ph1 negative chronic myelogenous leukaemia.

J D Rowley.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4135401      PMCID: PMC1013113          DOI: 10.1136/jmg.11.2.166

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  8 in total

1.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

2.  Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and cronic myeloid leukaemia (Ph1) by fluorescence.

Authors:  M L O'Riordan; J A Robinson; K E Buckton; H J Evans
Journal:  Nature       Date:  1971-03-19       Impact factor: 49.962

3.  Muramidase studies in Philadelphia-chromosome-positive and chromosome-negative chronic granulocytic leukemia.

Authors:  P E Perillie; S C Finch
Journal:  N Engl J Med       Date:  1970-08-27       Impact factor: 91.245

4.  Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis.

Authors:  T Caspersson; G Gahrton; J Lindsten; L Zech
Journal:  Exp Cell Res       Date:  1970-11       Impact factor: 3.905

5.  Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia.

Authors:  E Z Ezdinli; J E Sokal; L Crosswhite; A A Sandberg
Journal:  Ann Intern Med       Date:  1970-02       Impact factor: 25.391

6.  The aneuploid, Ph-1-positive cell population during progression and treatment of chronic myelogenous leukaemia.

Authors:  B Pedersen
Journal:  Acta Pathol Microbiol Scand       Date:  1966

7.  Chromosome studies in preleukemia. I. Aneuploidy of group C chromosomes in three patients.

Authors:  J D Rowley; R K Blaisdell; L O Jacobson
Journal:  Blood       Date:  1966-06       Impact factor: 22.113

8.  Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML).

Authors:  J Whang-Peng; G P Canellos; P P Carbone; J H Tjio
Journal:  Blood       Date:  1968-11       Impact factor: 22.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.